Skip to main content

MED

L3 Foundation Bolsters Childhood Cancer Research Through Large Gift to Sanford Health Foundation

Feb 16, 2021 01:03PM ● By Med Magazine
The L3 Foundation – short for Live, Love, Landon – has made a significant gift of $250,000 through the Sanford Health Foundation. The donation will go directly to childhood cancer research in an effort to find more effective treatments for young patients facing cancer.

The L3 Foundation was formed to honor Landon Ahrendt’s final wishes before he lost his life to cancer. At just 10-years-old, Landon asked his parents, Scott and Jaymi, to help other kids and families in their battles against cancer. Since Landon passed away in 2014, L3 has rallied passionate support and raised funds to advance pediatric cancer research and programs, like Camp Bring It On!, for kids and families. Along with the generosity of Scott’s brother, Jason Ahrendt, and his wife, Heather, L3 and the Ahrendt family have given nearly $1 million to honor Landon’s final wish.

“Our team at Sanford is humbled by this chance to partner with the L3 Foundation and help give new hope to kids and families fighting pediatric cancer,” said Sharon Hunt, vice president of research operations for Sanford. “These dollars will help drive progress in pediatric soft tissue cancer research, an area of research that deserves more attention and funding. We’re committed to driving collaboration and making sure the momentum continues through all phases of research.”

The Texas-based L3 Foundation chose to work with Sanford because of the organization’s access and participation in innovative phase 1 clinical trials. These studies are the first in a four-phase process of testing treatments in people. Sanford has invested in the staff and infrastructure to support these complex studies in effort to accelerate more effective, accessible and less toxic treatments to patients, especially those with the fewest options for treatment.

In conjunction with the gift from the L3 Foundation, Sanford is launching a larger program of pilot trails through its oncology research program. Researchers and teams can now apply for grants to advance treatment or research cures for various types of cancer. Program organizers hope to work through two or three trials annually, with at least one of those trials focused on pediatric soft tissue cancer.

Grant recipients do not need to be employed by Sanford, but will collaborate with Sanford physicians and researchers.